A Curated Platform of Equity & Options Market Intelligence
Select Page

UTHR

Search by
TICKER SYMBOL

United Therapeutics Corp

Sector: Manufacturing
Industry: Pharmaceutical Preparation Manufacturing

217.05

-1.87

(-0.854%)

Volume:

378,640

52 week range:

173.22 - 283.09

Market Cap:

10.05B

Company Description:

United Therapeutics Corporation focuses on the strength of a balanced, value-creating biotechnology model. We are confident in our future thanks to our fundamental attributes, namely our obsession with quality and innovation, the power of our brands, our entrepreneurial culture and our bioinformatics leadership. We also believe that our determination to be responsible citizens - having a positive impact on patients, the environment and society - will sustain our success in the long term. Through our wholly-owned subsidiary, Lung Biotechnology PBC, we are focused on addressing the acute national shortage of transplantable lungs and other organs with a variety of technologies that either delay the need for such organs or expand the supply. Lung Biotechnology is the first public benefit corporation subsidiary of a public biotechnology or pharmaceutical company.